Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
Sameena Khan, Deborah J. Burt, Christy Ralph, Fiona C. Thistlethwaite, Robert E. Hawkins, Eyad ElkordVolume:
138
Année:
2011
Langue:
english
Pages:
12
DOI:
10.1016/j.clim.2010.09.011
Fichier:
PDF, 2.84 MB
english, 2011